CRWD vs ORCL: Which Is the Better Buy?

Side-by-side comparison of CrowdStrike Holdings, Inc. and Oracle Corporation β€” fair value, conviction, valuation metrics, and QuantHub research signals. Updated 2026-09-25.
CrowdStrike Holdings, Inc. Β· Technology
$259.67
-13.1% upside to fair value
Low Conviction Grade C High Quality
VS
Oracle Corporation Β· Technology
$149.12
+45.0% upside to fair value
Med Conviction Grade B High Quality
QuantHub Verdict
ORCL has more upside to fair value (+45.0%). These are model outputs β€” not personalized investment advice. See all research β†’
Valuation & Fundamentals
Metric CRWD ORCL
Current Price $259.67 $149.12
Fair Value Estimate $225.56 $216.22
Upside to Fair Value -13.1% +45.0%
Market Cap $264.4B $429.5B
Forward P/E β€” β€”
EV / EBITDA 595.7x 14.6x
Price / Sales 49.0x 6.0x
Price / FCF 167.9x β€”
Revenue Growth YoY +25.8% +29.6%
Gross Margin 75.2% 63.9%
Operating Margin -2.2% 32.4%
Return on Equity 1.3% 42.6%
Dividend Yield 0% 1.34%
FCF Yield 0.6% β€”
Analyst Consensus Strong Buy Strong Buy
Investment Thesis
CRWD β€” CrowdStrike Holdings, Inc.
CrowdStrike Holdings is a cloud-native cybersecurity platform company that sells subscriptions to its Falcon platform and a growing array of cloud modules spanning endpoint protection, cloud workload security, identity protection, Next-Gen SIEM, threat intelligence, and managed services, generating revenue through a direct sales force and channel partners from its Austin, Texas headquarters with …
ORCL β€” Oracle Corporation
Oracle is a global enterprise software and cloud infrastructure provider whose portfolio spans the Oracle Database, Java, Fusion Cloud SaaS applications (ERP, EPM, SCM, HCM), NetSuite, and Oracle Cloud Infrastructure, sold through a direct sales force to businesses, governments, and educational institutions worldwide. The business quality is high on fundamentals: trailing-twelve-month gross margi…
Accumulation Zones
Metric CRWD ORCL
Zone Low $169.17 $162.16
Zone High $191.73 $183.79
In Buy Zone? No Yes
← CRWD Research    ORCL Research β†’    All Research